In most gene therapy studies, a ‘‘normal’’ gene is inserted into
the genome to replace an ‘‘abnormal’’ disease-causing gene. A
carrier molecule called a vector must be used to deliver the
therapeutic gene to the patient’s target cells. The vector then
unloads its genetic material containing the therapeutic
human gene into the target cell. The generation of a functional
protein product from the therapeutic gene restores the target
cell to a normal state.